← Insider buys
KITE

Kite Pharma, Inc.

EVP, Business Development Helen Susan Kim sold $2.2M of Kite Pharma, Inc.

Sold$2,163,825
$60.27Price
35,900Shares
−80%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Fri, Aug 12. Filed Tue, Aug 16, 4:16 PM ET, after the close. Not investment advice.